Last reviewed · How we verify

Hypofractionated Radiation Therapy for Merkel Cell Carcinoma

NCT05100095 PHASE2 RECRUITING

This phase II trial tests whether hypofractionated radiation works to treat patients with Merkel cell carcinoma. Radiation therapy uses high energy radio waves to kill cancer cells and shrink tumors. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may be more convenient for patients and less immunosuppressive.

Details

Lead sponsorM.D. Anderson Cancer Center
PhasePHASE2
StatusRECRUITING
Enrolment52
Start dateTue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionFri Sep 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

United States